Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jarman

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Biochemical Pharmacology|July 19, 1994
Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivativesJ Kirk, S K Syed, A L Harris, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1984
Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolitesA B Foster, L J Griggs, I Howe, et al.
British Journal of Haematology|August 8, 1998
Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) miceR D Clutterbuck, B C Millar, R L Powles, et al.
Journal of Enzyme Inhibition|January 1, 1992
Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptorJ H Davies, R J Shearer, M G Rowlands, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patientsG K Poon, Y C Chui, R McCague, et al.
Biomedical Mass Spectrometry|October 1, 1984
Metabolism of 1,1,1,2,2-pentafluorohexane and 1,1-difluorocyclohexane by rat liver microsomes in vitroM H Baker, A B Foster, L Hegedus, et al.
Biochemical Pharmacology|May 11, 1995
The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studiesH M Coley, N Brooks, D H Phillips, et al.
Journal of Hospital Medicine|July 17, 2010
A descriptive case series of patients with end-stage liver disease hospitalized with variceal bleeding who received pharmacologic venous thromboembolism prophylaxisAnneliese M Schleyer, Mark W Smith, Kenneth M Jarman, et al.
Cancer Research|August 1, 1978
Isolation and identification of a metabolic intermediate in the selective dechloroethylation of one of the four stereoisomers of 4-methylcyclophosphamideG Abel, P J Cox, P B Farmer, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
New endocrine agents for the treatment of breast cancerR C Coombes, M Jarman, M Dowsett, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Biochemical Pharmacology|July 19, 1994
Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivativesJ Kirk, S K Syed, A L Harris, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1984
Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolitesA B Foster, L J Griggs, I Howe, et al.
British Journal of Haematology|August 8, 1998
Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) miceR D Clutterbuck, B C Millar, R L Powles, et al.
Journal of Enzyme Inhibition|January 1, 1992
Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptorJ H Davies, R J Shearer, M G Rowlands, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patientsG K Poon, Y C Chui, R McCague, et al.
Biomedical Mass Spectrometry|October 1, 1984
Metabolism of 1,1,1,2,2-pentafluorohexane and 1,1-difluorocyclohexane by rat liver microsomes in vitroM H Baker, A B Foster, L Hegedus, et al.
Biochemical Pharmacology|May 11, 1995
The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studiesH M Coley, N Brooks, D H Phillips, et al.
Journal of Hospital Medicine|July 17, 2010
A descriptive case series of patients with end-stage liver disease hospitalized with variceal bleeding who received pharmacologic venous thromboembolism prophylaxisAnneliese M Schleyer, Mark W Smith, Kenneth M Jarman, et al.
Cancer Research|August 1, 1978
Isolation and identification of a metabolic intermediate in the selective dechloroethylation of one of the four stereoisomers of 4-methylcyclophosphamideG Abel, P J Cox, P B Farmer, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1993
New endocrine agents for the treatment of breast cancerR C Coombes, M Jarman, M Dowsett, et al.
Pageof 19